Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain

Toshiba America Medical Systems, Inc.30 enrolled

Overview

The purpose of this study will evaluate new technologies that have been included in the new PCA-9000A PET/CT System.

Scope: To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the study has the following 3 goals. * Define and confirm all supported clinical protocols from Low-Dose CT, to PET acquisition and presentation. * Verification of the quantitative accuracy of the imaging chain. * Evaluate the performance and stability of the new system and its related quality control and calibration procedures. Result (Expected): The study is an essential step in assessing the quality of the hardware and software defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition, reconstruction, correction, filtering, and presentation will be estimated or adjusted during this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its intended use.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Confirm PCA-9000A PET/CT System is Effective for Its Intended Use

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion: * Patients already scheduled for an FDG test at SDMI * 40 years and older * Adult must be able to sign an informed consent form Exclusion * Patients not scheduled for an FDG test at SDMI * 39 years or younger * Pregnant adult female or plan to be pregnant * Adult who is unable to sign the informed consent

Locations (1)

Steinberg Diagnostic Medical Imaging Centers

Henderson, Nevada, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.